Case Series of Three Patients with Rifampicin-Induced Thrombocytopenia-Reference-Cited by-同舟云学术

Case Series of Three Patients with Rifampicin-Induced Thrombocytopenia

Published:2020-10-16 Issue:01 Volume:11 Page:44-46
ISSN:2582-4287
Container-title:Journal of Health and Allied Sciences NU
language:en
Short-container-title:Journal of Health and Allied Sciences NU

Author:

M.T Chandramouli¹

Affiliation:

1. Department of Pulmonary Medicine, K.S. Hegde Medical Academy, Mangalore, Karnataka, India

Abstract

AbstractLife-threatening adverse reactions of antitubercular drugs are uncommon; however, thrombocytopenia is one such rare complication encountered with rifampicin, isoniazid, ethambutol, and pyrazinamide. Rifampicin is the most effective drug and its use in the tuberculosis treatment led to the emergence of modern and effective short-course regimens. I am reporting case series of three patients with pulmonary tuberculosis presented with rifampicin-induced thrombocytopenia.

Publisher

Georg Thieme Verlag KG

Subject

Ocean Engineering

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0040-1718608.pdf

Reference12 articles.

1. Adverse reactions to first-line anti-tuberculous agents in hospitalized patients: pattern, causality, severity and risk factors;K M Shinde;Indian J Med Spec.,2013

2. Drug-induced thrombocytopenia: a systematic review of published case reports;J N George;Ann Intern Med,1998

3. Adverse reactions to rifampicin;D J Girling;Bull World Health Organ,1979

4. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient;L D Wazny;Pharmacotherapy,2000

5. Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment;Berardino L Di;Am Rev Respir Dis,1976